The Nutshell

» disease/medicine, evolution and funding

Daily News Roundup

Most Recent

image: Proposed NIH Grant Cap Criticized

Proposed NIH Grant Cap Criticized

By | June 8, 2017

Update: The agency announced it will ditch the proposal, and set up a fund for early- to mid-career scientists instead.

0 Comments

The new fossils push the origin of the human species back by 100,000 years.

0 Comments

image: Age-Related Bias in NIH Awards

Age-Related Bias in NIH Awards

By | June 6, 2017

The number of young investigators with NIH grants has declined since 1982, but recent efforts by the agency to increase funding for early-stage investigators are working, a study finds.

0 Comments

The new findings, obtained from cell culture experiments, could explain the link between infection with the virus during pregnancy and infant microcephaly.

1 Comment

Clinical medicine and biosciences are among the UK disciplines that receive the most EU funding.

0 Comments

Harvesting lab-raised zebrafish based on their size led to differences in the activity of more than 4,000 genes, as well as changes in allele frequencies of those genes, in the fish that remained.

0 Comments

National opinions about the effectiveness of last month’s science and climate marches are mixed and follow political lines, a Pew survey reports.

2 Comments

image: Zika's Economic Burden

Zika's Economic Burden

By | May 11, 2017

A new analysis estimates that the viral disease could cost between $183 million and more than $10 billion in the U.S. alone. 

1 Comment

New research provides evidence that the ancient hominin species might not be so ancient after all.

0 Comments

If made law, the American Health Care Act passed today in the US House would eliminate the Obamacare-funded initiative.

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Authors Peeved by APA’s Article Takedown Pilot
  3. Athletes’ Microbiomes Differ from Nonathletes
  4. Was a Drop in CRISPR Firms’ Stock Warranted?
AAAS